Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Griffiths

Showing results (1241-1250 of 1,887) with videos related to

Pageof 189
Sort By:
BMC Family Practice|June 8, 2010
A qualitative study of the views of patients with long-term conditions on family doctors in Hong KongStewart W Mercer, Judy Y Siu, Sheila M Hillier, et al.
The British Journal of Dermatology|May 15, 2021
Patient preferences for stratified medicine in psoriasis: a discrete choice experimentG Dalal, S J Wright, C M Vass, et al.
Plant Disease|March 6, 2019
Responses of 11 Fraxinus Cultivars to Ash Yellows Phytoplasma Strains of Differing AggressivenessW A Sinclair, M L Gleason, H M Griffiths, et al.
Radiology|September 23, 2006
Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening ProgramFiona J Gilbert, Susan M Astley, Magnus A McGee, et al.
BMC Health Services Research|November 27, 2013
Patients' socioeconomic status and their evaluations of primary care in Hong KongOnikepe Owolabi, Zhenzhen Zhang, Xiaolin Wei, et al.
Lancet (London, England)|October 18, 2005
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trialKristian Reich, Frank O Nestle, Kim Papp, et al.
JAMA Dermatology|July 6, 2022
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With PsoriasisZenas Z N Yiu, Gabrielle Becher, Brian Kirby, et al.
The ISME Journal|June 27, 2018
Genetic variability and ontogeny predict microbiome structure in a disease-challenged montane amphibianSarah M Griffiths, Xavier A Harrison, Ché Weldon, et al.
The EMBO Journal|February 21, 1998
Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domainR Uellner, M J Zvelebil, J Hopkins, et al.
Dermatology and Therapy|February 23, 2022
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-AnalysisAndrew Blauvelt, Melinda Gooderham, Christopher E M Griffiths, et al.
Pageof 189

Showing results (1241-1250 of 1,887) with videos related to

Sort By:
Pageof 189
BMC Family Practice|June 8, 2010
A qualitative study of the views of patients with long-term conditions on family doctors in Hong KongStewart W Mercer, Judy Y Siu, Sheila M Hillier, et al.
The British Journal of Dermatology|May 15, 2021
Patient preferences for stratified medicine in psoriasis: a discrete choice experimentG Dalal, S J Wright, C M Vass, et al.
Plant Disease|March 6, 2019
Responses of 11 Fraxinus Cultivars to Ash Yellows Phytoplasma Strains of Differing AggressivenessW A Sinclair, M L Gleason, H M Griffiths, et al.
Radiology|September 23, 2006
Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening ProgramFiona J Gilbert, Susan M Astley, Magnus A McGee, et al.
BMC Health Services Research|November 27, 2013
Patients' socioeconomic status and their evaluations of primary care in Hong KongOnikepe Owolabi, Zhenzhen Zhang, Xiaolin Wei, et al.
Lancet (London, England)|October 18, 2005
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trialKristian Reich, Frank O Nestle, Kim Papp, et al.
JAMA Dermatology|July 6, 2022
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With PsoriasisZenas Z N Yiu, Gabrielle Becher, Brian Kirby, et al.
The ISME Journal|June 27, 2018
Genetic variability and ontogeny predict microbiome structure in a disease-challenged montane amphibianSarah M Griffiths, Xavier A Harrison, Ché Weldon, et al.
The EMBO Journal|February 21, 1998
Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domainR Uellner, M J Zvelebil, J Hopkins, et al.
Dermatology and Therapy|February 23, 2022
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-AnalysisAndrew Blauvelt, Melinda Gooderham, Christopher E M Griffiths, et al.
Pageof 189